Serina Therapeutics, Inc. Assets, Fair Value Adjustment
Serina Therapeutics, Inc. (SER) reported Assets, Fair Value Adjustment of $663.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes
us-gaap:AssetsFairValueAdjustment · last filed 2023-11-14
- Serina Therapeutics, Inc. assets, fair value adjustment for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Serina Therapeutics, Inc. assets, fair value adjustment for the quarter ending 2023-06-30 was $0.00.
- Serina Therapeutics, Inc. assets, fair value adjustment for the quarter ending 2023-03-31 was $663.00K, a 83.84% decline year-over-year.
- Serina Therapeutics, Inc. assets, fair value adjustment for the quarter ending 2022-09-30 was $341.00K.
| Period end | Assets, Fair Value Adjustment 3 month | Assets, Fair Value Adjustment 6 month | Assets, Fair Value Adjustment 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $663.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $663.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $663.00K 10-Q · filed 2023-05-12 | ||
| 2022-09-30 | $341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$437.00K derived: sum of 2 quarters · filed 2023-11-14 | $3.67M 10-Q · filed 2023-11-14 |
| 2022-06-30 | -$778.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.33M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $4.10M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |